Bristol-Myers, with partner Pfizer, is testing factor 10a blocker apixaban in a giant 15, 000-patient trial on preventing stroke.

FORBES: Magazine Article

Another related drug, called apixaban from Bristol-Myers Squibb and Pfizer, might have less bleeding when clinical trial results read out next year.

FORBES: Names You Need To Know: Pradaxa and Xarelto

Apixaban (tradename: Eliquis) is a novel anticoagulant for the prevention of stroke and other thromboembolic events that is awaiting FDA approval.

FORBES: Why Is Pharma Out-Licensing Its Compounds?